Interleukin-5 Receptor alpha-directed Cytolytic Antibody
- Name
- Interleukin-5 Receptor alpha-directed Cytolytic Antibody
- Accession Number
- DBCAT003992
- Description
Not Available
- Drugs
Drug Drug Description Benralizumab A monoclonal antibody used to treat eosinophilic asthma. - Drugs & Drug Targets
Drug Target Type Benralizumab Interleukin-5 receptor subunit alpha target Benralizumab Low affinity immunoglobulin gamma Fc region receptor III-A target